Pharmacological control of CAR T-cells by dasatinib
Cellular therapies using chimeric antigen receptor (CAR) modified T cells to eradicate tumor cells have been a major breakthrough in the treatment of hematologic malignancies. However, there are no measures to control CAR T cell activity after infusion, which is mostly required in cases of CAR T cel...
| Main Author: | |
|---|---|
| Format: | Doctoral Thesis |
| Language: | English |
| Published: |
2020
|
| Subjects: | |
| Online Access: | https://opus.bibliothek.uni-wuerzburg.de/frontdoor/index/index/docId/18056 http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-180562 https://nbn-resolving.org/urn:nbn:de:bvb:20-opus-180562 https://opus.bibliothek.uni-wuerzburg.de/files/18056/Mestermann_Katrin_Thesis.pdf |